University of Texas Southwestern Medical Center: Lung Neoplasms trials

The registry lists 19 Lung Neoplasms studies with University of Texas Southwestern Medical Center as lead sponsor. 4 are open to participants now and 10 have results posted.

Early Phase 1 2Phase 1 6Phase 2 7Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1Not yet recruitingNCT07254650Not applicable
• Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungRecruitingNCT06712745Early Phase 1
• Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung CancerRecruitingNCT03563976
• Metabolic Biomarkers in Thoracic CancersRecruitingNCT02095808Not applicable
• Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung CancerCompletedNCT04003246Phase 2Results posted
• Phase I Study of Accelerated Hypofractionated Image-Guided Radiation TherapyCompletedNCT03623334Not applicableResults posted
• Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)TerminatedNCT03095612Phase 1/2Results posted
• Neoadjuvant Itraconazole in Non-small Cell Lung CancerCompletedNCT02357836Early Phase 1Results posted
• End-of-Life Care for African AmericansCompletedNCT02320123Not applicableResults posted
• Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II TrialCompletedNCT02045446Phase 2Results posted
• Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCCompletedNCT01757288Phase 1/2Results posted
• Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung CancerCompletedNCT01459497Phase 3Results posted
• Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT01302808Phase 1Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesWithdrawnNCT04889066Phase 2
• Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-IrradiationCompletedNCT02170181
• Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance StatusCompletedNCT00986297Phase 1
• Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung TumorsTerminatedNCT00866086Phase 1
• Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00547443Phase 1/2